These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 28148910)
1. Intein-mediated backbone cyclization of VP1 protein enhanced protection of CVB3-induced viral myocarditis. Qi X; Xiong S Sci Rep; 2017 Feb; 7():41485. PubMed ID: 28148910 [TBL] [Abstract][Full Text] [Related]
2. Spontaneous C-cleavage of a truncated intein as fusion tag to produce tag-free VP1 inclusion body nanoparticle vaccine against CVB3-induced viral myocarditis by the oral route. Qi X; Lu Q; Hu J; Xiong S Microb Cell Fact; 2019 Apr; 18(1):66. PubMed ID: 30947747 [TBL] [Abstract][Full Text] [Related]
3. AIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge. Yin L; Chai D; Yue Y; Dong C; Xiong S Front Cell Infect Microbiol; 2017; 7():247. PubMed ID: 28642849 [TBL] [Abstract][Full Text] [Related]
4. An Albumin-Binding Domain Peptide Confers Enhanced Immunoprotection Against Viral Myocarditis by CVB3 VP1 Vaccine. Gao Y; Yue Y; Xiong S Front Immunol; 2021; 12():666594. PubMed ID: 34630378 [No Abstract] [Full Text] [Related]
5. Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination. Lan J; Gao Z; Xiong H; Chuai X; Jin Y; Li J; Xian X; Liu G; Xie L; Zhang Y; Wang Y Vaccine; 2011 Sep; 29(40):6894-902. PubMed ID: 21803097 [TBL] [Abstract][Full Text] [Related]
6. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis. Zhang L; Parham NJ; Zhang F; Aasa-Chapman M; Gould EA; Zhang H Vaccine; 2012 Mar; 30(13):2301-8. PubMed ID: 22306858 [TBL] [Abstract][Full Text] [Related]
7. Incorporation of a bi-functional protein FimH enhances the immunoprotection of chitosan-pVP1 vaccine against coxsackievirus B3-induced myocarditis. Fan X; Yue Y; Xiong S Antiviral Res; 2017 Apr; 140():121-132. PubMed ID: 28137624 [TBL] [Abstract][Full Text] [Related]
8. M cell-targeting strategy facilitates mucosal immune response and enhances protection against CVB3-induced viral myocarditis elicited by chitosan-DNA vaccine. Ye T; Yue Y; Fan X; Dong C; Xu W; Xiong S Vaccine; 2014 Jul; 32(35):4457-4465. PubMed ID: 24958702 [TBL] [Abstract][Full Text] [Related]
9. Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle. Yue Y; Xu W; Hu L; Jiang Z; Xiong S Virology; 2009 Apr; 386(2):438-47. PubMed ID: 19233446 [TBL] [Abstract][Full Text] [Related]
10. Development of a enterovirus diagnostic assay system for diagnosis of viral myocarditis in humans. Lim BK; Ju ES; Lao DH; Yun SH; Lee YJ; Kim DK; Jeon ES Microbiol Immunol; 2013 Apr; 57(4):281-7. PubMed ID: 23586632 [TBL] [Abstract][Full Text] [Related]
11. Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditis. Chai D; Yue Y; Xu W; Dong C; Xiong S Hum Vaccin Immunother; 2014; 10(5):1284-94. PubMed ID: 24614684 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis. Zhou L; He X; Gao B; Xiong S J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170 [TBL] [Abstract][Full Text] [Related]
13. Mucosal immunization with high-mobility group box 1 in chitosan enhances DNA vaccine-induced protection against coxsackievirus B3-induced myocarditis. Wang M; Yue Y; Dong C; Li X; Xu W; Xiong S Clin Vaccine Immunol; 2013 Nov; 20(11):1743-51. PubMed ID: 24027262 [TBL] [Abstract][Full Text] [Related]
14. [A novel DNA vaccine containing endosome-fusogenic peptide prevents CVB3-induced myocarditis in mice]. Xu W; Shen Y; Chen RZ; Xiong SD Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):334-8. PubMed ID: 15059520 [TBL] [Abstract][Full Text] [Related]
15. T lymphocyte responses in CVB3-induced murine myocarditis. Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923 [TBL] [Abstract][Full Text] [Related]
16. A vesicular stomatitis virus-based mucosal vaccine promotes dendritic cell maturation and elicits preferable immune response against coxsackievirus B3 induced viral myocarditis. Wu F; Fan X; Yue Y; Xiong S; Dong C Vaccine; 2014 Jun; 32(31):3917-26. PubMed ID: 24874923 [TBL] [Abstract][Full Text] [Related]
17. Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection. Xu W; Shen Y; Jiang Z; Wang Y; Chu Y; Xiong S Vaccine; 2004 Sep; 22(27-28):3603-12. PubMed ID: 15315839 [TBL] [Abstract][Full Text] [Related]
18. Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication. Qiu Y; Ye X; Zhang HM; Hanson P; Zhao G; Tong L; Xie R; Yang D PLoS Pathog; 2017 Dec; 13(12):e1006744. PubMed ID: 29220410 [TBL] [Abstract][Full Text] [Related]
19. Distinct Th17 inductions contribute to the gender bias in CVB3-induced myocarditis. Li Z; Yue Y; Xiong S Cardiovasc Pathol; 2013; 22(5):373-82. PubMed ID: 23523188 [TBL] [Abstract][Full Text] [Related]
20. Exosomes derived from cardiac progenitor cells attenuate CVB3-induced apoptosis via abrogating the proliferation of CVB3 and modulating the mTOR signaling pathways. Li X; Yang Z; Nie W; Jiang J; Li S; Li Z; Tian L; Ma X Cell Death Dis; 2019 Sep; 10(10):691. PubMed ID: 31534118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]